About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Chicago | 109 Studies

Clinical Trials COPDChicago

COPD Clinical Trials in Chicago

Find 109 clinical trials for copd near Chicago, Illinois. Connect with research centers in your area.

All COPD trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 109 trials

CompletedA Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)The study evaluates the efficacy of fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI) to reduce the annual rate of moderate and severe exacerbations compared with…NCT02164513·Athens, Alabama and 997 others

PreviousPage 4 of 6Next

COPD Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedObservational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic…NCT00259909·Birmingham, Alabama and 122 others

Active not recruitingImpairments That Affect Correct Inhaler Use in COPDINHALE is a one-year, multi-site observational research study funded by Viatris, with two aims: 1.NCT06135324·Birmingham, Alabama and 8 others

CompletedAt Home Spirometry and Video Module Education for COPD PatientsThe central hypothesis is that patients hospitalized for COPD who subsequently complete the at-home BREATHES Program with V-TTG skill training and SpiroPD adherence support will…NCT03834350·Chicago, Illinois

CompletedTo Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDThe purpose of this study is to determine the long-term safety of arformoterol over a period of 12 months in subjects with COPDNCT00064415·Anniston, Alabama and 89 others

CompletedA 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to evaluate the dose-response of different doses of CHF 5259 pMDI on lung function and other clinical outcomes, to identify the optimal dose(s) in…NCT03084796·Birmingham, Alabama and 111 others

CompletedThe Reducing REVISITS Study: A Cluster RCTThis type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via…NCT05568043·Chicago, Illinois

CompletedEfficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)To evaluate the efficacy and safety of LAS 34273 compared to placebo in patients with moderate to severe COPD during one year of treatment.NCT00358436·Jasper, Alabama and 119 others

CompletedBone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.This study will last up to 3 years. You will visit the clinic up to 14 times.NCT00355342·Berkeley, California and 36 others

CompletedTeaching Use of Respiratory Inhalers (TURI)The purpose of this study is to evaluate the feasibility of enrolling and randomizing patients into one of two educational interventions to teach appropriate respiratory inhaler…NCT01456494·Chicago, Illinois

CompletedHealtheRx Survey for Pulmonary Research Registry RecruitmentThe purpose of this research is to study the utility of using the HealtheRx as a tool to recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the…NCT02653066·Chicago, Illinois

CompletedA Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD ExacerbationsThe purpose of this study is to evaluate the blood and airway of subjects with mild to moderate COPD while undergoing standard treatment.NCT00116402·Chicago, Illinois

CompletedEfficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsPhase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated…NCT04053634·Surprise, Arizona and 342 others

CompletedComparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseComparing the efficacy of Symbicort® pMDI and Formoterol Turbuhaler in reducing exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).NCT02157935·Andalusia, Alabama and 370 others

WithdrawnSafety Study of Nebivolol for COPD PatientsThe purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive…NCT01939990·Chicago, Illinois

TerminatedInhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)This open-label study will evaluate the safety of continued therapy with inhaled treprostinil in participants who have completed Study RIN-PH-304 (NCT03496623).NCT03794583·Birmingham, Alabama and 31 others

Active not recruitingRejuvenAir® System Trial for COPD With Chronic BronchitisChronic Obstructive Pulmonary Disease (COPD) is defined as an impaired ability to move air within the lungs and is a major public health problem that is projected to rank fifth…NCT03893370·Scottsdale, Arizona and 26 others

CompletedRoflumilast or Azithromycin to Prevent COPD Exacerbations TrialA multi-center, randomized, 72-month, parallel- group, non-inferiority, phase III study to compare the effectiveness of roflumilast (Daliresp, 500 mcg quaque die (QD) or alternate…NCT04069312·Birmingham, Alabama and 27 others

CompletedBenralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryThe purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of…NCT02138916·Andalusia, Alabama and 406 others

CompletedLosartan Effects on Emphysema ProgressionA randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to…NCT02696564·Birmingham, Alabama and 27 others

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia